ViroStat Introduces Set of New Monoclonal Antibodies to Gardnerella Vaginalis

Press Release Summary:

  • Do not cross-react with other agents including Chlamydia, Candida albicans and Neisseria gonorrhoeae
  • Function as pairs in ELISA and lateral flow immunoassay for antigen detection

Original Press Release:

New Monoclonal Antibodies to Gardnerella Vaginalis

Gardnerella vaginalis is a major species present in bacterial vaginosis. It is a small gram variable, anaerobic coccobacillus. Overgrowth of this bacterium occurs due to an imbalance of normal vaginal flora which can result from prescription antibiotics.

Microscopic evaluation often shows this bacterium associated with epithelial “clue cells”. Treatment with metronidazole or clindamycin is recommended.

ViroStat has just released a set of new monoclonal antibodies to Gardnerella vaginalis. These specific antibodies do not cross react with other agents including Chlamydia, Candida albicans and Neisseria gonorrhoeae. Several of the antibodies function as pairs in ELISA and lateral flow immunoassay for antigen detection.

Download data sheets for these antibodies at www.virostat-inc.com.

ViroStat is a primary manufacturer, supplying infectious disease reagents to researchers and rapid test manufacturers since 1985.

Contact ViroStat for your FREE copy of the NEW Catalogue at 207-856-6620 or view and download it online at www.virostat-inc.com.

ViroStat, Inc.

PO Box 8522

Portland, ME 04104 USA

Phone: 207-856-6620

Fax: 207-856-6864

E-mail: info@virostat-inc.com

Website: www.virostat-inc.com

Related

All Topics